PolitiFact Examines Trade Deals’ Potential Impacts On Indian Generic Drug Manufacturers, Access To Medicines

PolitiFact: Do trade deals threaten India as low-cost HIV drug maker?
“…Doctors Without Borders said that trade deals threaten the capacity of Indian generic drug makers to produce the next round of HIV drugs. We found that trade negotiations, whether part of large regional trade agreements or unilateral discussions between the United States and India, have language that work against India generic drug makers. … Our experts disagreed on whether this would reduce access to critical drugs. The trade deals do no favors for India’s generic drug makers. With a caveat about future access to drugs, we rate this claim Mostly True” (Greenberg, 8/3).